Technical analysis of Bluejay Diagnostics, Inc. (BJDX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force.
Price Performance
| 1 month | -16.25% |
| 3 months | -81.78% |
| Year-to-date | -69.57% |
| 1 year | -86.90% |
| 3 years | -99.98% |
52-Week Range
| 52-week High | $16.68 |
| 52-week Low | $0.80 |
| Avg Volume (90d) | 4.8M |
Technical Indicators
| SMA 50 | $1.04 |
| SMA 200 | $2.29 |
| 30-day Volatility (annualised) | 109.3% |
| Price vs SMA 50 | -21.7% |
| Price vs SMA 200 | -64.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $7.88 | |
| 2025-11 | $5.20 | -34.0% |
| 2025-12 | $2.67 | -48.7% |
| 2026-01 | $3.62 | +35.6% |
| 2026-02 | $2.05 | -43.4% |
| 2026-03 | $1.84 | -10.2% |
| 2026-04 | $1.81 | -1.6% |
| 2026-05 | $2.14 | +18.2% |
| 2026-06 | $1.20 | -43.9% |
| 2026-07 | $0.86 | -28.3% |
| 2026-08 | $0.87 | +1.2% |
| 2026-09 | $0.81 | -6.6% |
Price
| Price | $0.81 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.18 |
| EV / EBITDA | 1.21 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 4.64 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.03 |